for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Shanghai Fosun Pharmaceutical (Group)

600196.SS

Latest Trade

27.29CNY

Change

-0.71(-2.54%)

Volume

13,310,412

Today's Range

27.18

 - 

27.95

52 Week Range

20.61

 - 

32.25

As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
28.00
Open
27.95
Volume
13,310,412
3M AVG Volume
356.34
Today's High
27.95
Today's Low
27.18
52 Week High
32.25
52 Week Low
20.61
Shares Out (MIL)
2,562.90
Market Cap (MIL)
67,959.55
Forward P/E
22.11
Dividend (Yield %)
1.14

Latest Developments

More

Shanghai Fosun Pharmaceutical Group Says Fosun High Tech Bought 1.1 Mln H Shares

Fosun International Says Final Offer Price Of Shanghai Henlius H Shares Is HK$49.60/ Share

Shanghai Fosun Pharmaceutical's H1 Net Profit Down 2.8% Y/Y

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Shanghai Fosun Pharmaceutical (Group)

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company's products are mainly applied in the treatment of metabolism and digestive tract system, cardiovascular system, central nervous system, blood system, anti-tumor and anti-infection diseases. The Company is also engaged in medical equipment and medical diagnosis business, as well as the provision of medical services. It distributes its products primarily in domestic and overseas markets.

Industry

Major Drugs

Contact Info

Building A, No. 1289 Yishan Road

+86.21.33987870

http://www.fosunpharma.com

Executive Leadership

Qiyu Chen

Chairman of the Board, Executive Director

Fang Yao

Co-Chairman of the Board, Executive Director

Yifang Wu

President, Chief Executive Officer, Executive Director

Xiaohui Guan

Chief Financial Officer, Senior Vice President, Chief Accounting Officer

Yuqing Chen

Senior Vice President

Key Stats

1.94 mean rating - 16 analysts
Sell
Hold
Buy
Revenue (MM, CNY)

2016

14.5K

2017

18.5K

2018

24.9K

2019(E)

29.7K
EPS (CNY)

2016

1.200

2017

1.270

2018

1.070

2019(E)

1.267
Price To Earnings (TTM)
26.85
Price To Sales (TTM)
2.50
Price To Book (MRQ)
2.50
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
81.75
LT Debt To Equity (MRQ)
52.23
Return on Investment (TTM)
7.08
Return on Equity (TTM)
4.43

Latest News

UPDATE 1-China's Fosun Pharma stock tumbles after regulator's spot check on subsidiary

* Share price falls as much as 10 pct (Adds pictures to media information)

China's Fosun Pharma stock tumbles after regulator's spot check on subsidiary

Shanghai Fosun Pharmaceutical Group Co Ltd saw its shares tumble by as much as 10 percent on Friday after it said regulators had made an unannounced inspection of a subsidiary prompted by a letter detailing alleged violations.

BRIEF-Shanghai Fosun Pharmaceutical's Unit To Invest In Amerigen Pharmaceuticals' Bonds

* SAYS UNIT SIGNS FUNDING AGREEMENT TO INVEST $10 MILLION IN AMERIGEN PHARMACEUTICALS' CONVERTIBLE BONDS Source text in Chinese: http://bit.ly/2E7YM1R Further company coverage: (Reporting by Hong Kong newsroom)

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up